rs3924231
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006129.5(BMP1):c.1180+116A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 855,576 control chromosomes in the GnomAD database, including 20,818 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.27 ( 7012 hom., cov: 33)
Exomes 𝑓: 0.18 ( 13806 hom. )
Consequence
BMP1
NM_006129.5 intron
NM_006129.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
BMP1 (HGNC:1067): (bone morphogenetic protein 1) This gene encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors. This gene is expressed as alternatively spliced variants that share an N-terminal protease domain but differ in their C-terminal region. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 8-22192267-A-G is Benign according to our data. Variant chr8-22192267-A-G is described in ClinVar as [Benign]. Clinvar id is 675112.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.482 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMP1 | NM_006129.5 | c.1180+116A>G | intron_variant | ENST00000306385.10 | NP_006120.1 | |||
BMP1 | NM_001199.4 | c.1180+116A>G | intron_variant | ENST00000306349.13 | NP_001190.1 | |||
BMP1 | NR_033403.2 | n.1251+116A>G | intron_variant | |||||
BMP1 | NR_033404.2 | n.1251+116A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMP1 | ENST00000306385.10 | c.1180+116A>G | intron_variant | 1 | NM_006129.5 | ENSP00000305714.5 | ||||
BMP1 | ENST00000306349.13 | c.1180+116A>G | intron_variant | 1 | NM_001199.4 | ENSP00000306121.8 |
Frequencies
GnomAD3 genomes AF: 0.272 AC: 41350AN: 151856Hom.: 6991 Cov.: 33
GnomAD3 genomes
AF:
AC:
41350
AN:
151856
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.184 AC: 129567AN: 703602Hom.: 13806 Cov.: 9 AF XY: 0.182 AC XY: 66029AN XY: 363790
GnomAD4 exome
AF:
AC:
129567
AN:
703602
Hom.:
Cov.:
9
AF XY:
AC XY:
66029
AN XY:
363790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.273 AC: 41423AN: 151974Hom.: 7012 Cov.: 33 AF XY: 0.276 AC XY: 20534AN XY: 74290
GnomAD4 genome
AF:
AC:
41423
AN:
151974
Hom.:
Cov.:
33
AF XY:
AC XY:
20534
AN XY:
74290
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
672
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at